WHERE SCIENCE COMES TO LIFE

The Problem The development of a biomarker for hypoxic tissues is essential both for diagnostic formulation and treatment planning for most cancer patients. Although the current PET radiotracers are non-invasive imaging modality techniques of tumor hypoxia, they are not being used routinely due to slow uptake by hypoxic. Cu(II)-tracers have been suggested to become one…